Cardiovascular disease (CVD) is among the most frequent chronic diseases in the Netherlands. So, prevention is of high importance and primary care could play an important role. The cornerstone of CVD prevention is lifestyle change. However,…
ID
Bron
Verkorte titel
Aandoening
Cardiovascular disease, prevention, lifestyle intervention
Ondersteuning
Primary Care Group The Hague (ELZHA)
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Primary outcome is the difference in mean proportion of achievement of individual lifestyle goals between the control group (all patients during usual preventive care) and the intervention group (all patients during combined usual preventive care and group-based intervention).
Achtergrond van het onderzoek
In the Healthy Heart project we evaluate two prevention strategies (individual usual care and a group-based lifestyle program) in a real-life primary care setting. Usual preventive care consists of one to four individual consultations during one year with a primary care nurse, specialized in cardiovascular care and trained for lifestyle education. During the intervention period patients proceed, based on shared-decision-making, with usual preventive care or follow the integrated group-based lifestyle program. Patients who choose to follow the group-based lifestyle program, attend seven to ten group sessions during 4 to 6 months in groups of 10 persons. During the group sessions, all aspects of lifestyle change (smoking, alcohol intake, diet, overweight, physical activity) are discussed by a lifestyle coach.
Doel van het onderzoek
Cardiovascular disease (CVD) is among the most frequent chronic diseases in the Netherlands. So, prevention is of high importance and primary care could play an important role. The cornerstone of CVD prevention is lifestyle change. However, knowledge on effectiveness and implementation of lifestyle intervention programmes in primary care is scarce. This project adds valuable knowledge of effect and successful implementation of integrated lifestyle intervention in primary care. Furthermore, food security status will be assessed which is an important risk factor for CVD.
Onderzoeksopzet
Patients will be included during consultation with the general practitioner or primary care nurse. Using questionnaires at baseline and 3, 6, 12 and 24 months after inclusion, we will assess achievement of individual lifestyle goals and change of lifestyle. Furthermore, all eligible patients will be asked to complete a questionnaire about barriers and facilitators to participation in this project. Routine care data will be used to compare blood pressure and cholesterol levels between patient groups.
Onderzoeksproduct en/of interventie
In this project we evaluate two prevention strategies (individual usual care and a group-based lifestyle program) in a real-life primary care setting, using a stepped-wedge observational cohort design. During the control period patients will be offered usual preventive care only. Usual preventive care consists of one to four individual consultations during one year with a primary care nurse, specialized in cardiovascular care and trained for lifestyle education. During the intervention period patients proceed, based on shared-decision-making, with usual preventive care or follow the integrated group-based lifestyle program. Patients who choose to follow the group-based lifestyle program, attend seven to ten group sessions during 4 to 6 months in groups of 10 persons. During the group sessions, all aspects of lifestyle change (smoking, alcohol intake, diet, overweight, physical activity) are discussed by a lifestyle coach.
Publiek
S.M. Verkleij
Postbus 9600
Leiden 2300 RC
The Netherlands
S.M.Verkleij@lumc.nl
Wetenschappelijk
S.M. Verkleij
Postbus 9600
Leiden 2300 RC
The Netherlands
S.M.Verkleij@lumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- Patients must be registered at primary care practices connected to Primary Care Group The Hague (ELZHA; Eerstelijns Zorggroep Haaglanden).
- Patients must be identified as high risk patients, which corresponds to a 10-year cardiovascular risk of >10% according to Dutch guidelines.
For the selection of high risk patients the following ICPC codes will be used, namely hypertension uncomplicated (K86), hypertension complicated (K87) and lipid disorder (T93). In addition, the following ATC codes will be used, namely cardiac therapy (C01), antihypertensive drugs (CO2), diuretic drugs (CO3), peripheral vasodilators (C04), vasoprotective drugs (G05), beta blocking agents (C07), calcium channel blockers (C08), agents acting on the renin-angiotensin system (C09) and lipid modifying agents (G10).
- Patients must be capable of giving informed consent (IC).
Primary care practices connected to ELZHA are eligible to participate in this study if data on blood pressure, fasting serum lipid profile and smoking status are accessible through patient records in at least 70% of their high risk population.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Patients who have an ICPC coded diagnosis of cardiovascular disease will be excluded.
For the exclusion of CVD patients the following ICPC codes will be used, namely ischemic heart disease with angina pectoris (K74), acute myocardial infarction (K75), ischemic heart disease without angina pectoris (K76), transient cerebral ischemia (K89), cerebral infarction (K90.03), intermittent claudication (K92.01) and aortic aneurysm (K99.01).
- Patients who have an ICPC coded diagnoses of diabetes mellitus (T90) will be excluded.
- Patients living in nursing homes will be excluded.
- Patients with dementia will be excluded.
- Patients with major comorbidity, for example patients who are terminally ill, will be excluded, based on judgment of the general practitioner.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL6834 |
| NTR-old | NTR7071 |
| Ander register | NL60795.058.17 ABR-form CCMO : P17.079 METC Leiden University Medical Center |